Overview

A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease

Status:
COMPLETED
Trial end date:
2024-06-17
Target enrollment:
Participant gender:
Summary
An Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Phase:
PHASE4
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
perfluorohexyl-octan